Gene amplification methods

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S070100, C435S071100

Reexamination Certificate

active

07405060

ABSTRACT:
The present invention provides multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias). The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune cell tumors malignancies as well as methods of treating immune cell tumors using custom vaccines.

REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4656134 (1987-04-01), Ringold
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4956288 (1990-09-01), Barsoum
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5043270 (1991-08-01), Abrams et al.
patent: 5122464 (1992-06-01), Wilson et al.
patent: 5179017 (1993-01-01), Axel et al.
patent: 5270202 (1993-12-01), Raychaudhuri
patent: 6235280 (2001-05-01), Chatterjee et al.
patent: 6632431 (2003-10-01), Wu
patent: 0 307 285 (1989-03-01), None
patent: 0 433 900 (1991-06-01), None
patent: 91/13632 (1991-09-01), None
patent: 94/08601 (1994-04-01), None
Gura (Science, v278, 1997, pp. 1041-1042).
Weiner L.M., Seminars Oncology, vol. 26, No. 4, Suppl 12, pp. 41-50, 1999.
Cleary et al (Cell, 1986, vol. 44, pp. 97-106).
Levy et al (Journal of Experimental Medicine, 1988, vol. 168, pp. 475-489).
Embleton et al (Nucleic Acids Research, 1992, vol. 20, pp. 3831-3837).
Kunkel et al., (1987) “Rapid and Efficient Site-Specific Mutagenesis Without Phenotypic Selection,”Methods in Enzymology154:367-382.
Russel et al., (1986) “An Improved Filamentous Helper Phage for Generating Single-Stranded Plasmid DNA,”Gene45:333-338.
Bell et al., (1985) “DNA Sequence and Characterization of Human Class II Major Histocompatibility Complex β Chains From the DRI Haplotype,”Proc. Natl. Acad. Sci. USA82:3405-3409.
Mosmann et al., (1990) “Isolation of Monoclonal Antibodies Specific for IL-4,IL-5, IL-6, and a New Th2-Specific Cytokine (IL-10), Cytokine Synthesis Inhibitory Factory, By Using a Solid Phase Radioimmunoadsorbent Assay,”J. Immunol.145:2938-2945.
Cloning by Limiting Dilution, in Current Protocols in Immunology(J.E. Coligan et al., eds.) John Wiley & Sons, New York, section 2.5.10-2.5.11.
Lampson and Levy (1980) “Two Populations of Ia-Like Molecules on a Human B Cell Line,”J. Immunol., 125:293-299.
Harlow and Lane, (1988) eds.,Antibodies: A Laboratory Manual, Cold Spring Harbor Press, New York, pp. 272, 276, 341.
Kwak et al., (1992) “Induction of Immune Responses in Patients With B-Cell Lymphoma Against The Surface-Immunoglobulin Idiotype Expressed By their Tumors,”N. Engl. J. Med.327:1209-1215.
Hsu et al., (1996) “Vaccination of Patients with B-Cell Lymphoma Using Autologous Antigen-Pulsed Dendritic Cells,”Nature Med.2:52-58.
Cosson and Bonifacino, (1992) “Role of Transmembrane Domain Interactions in the Assembly of Class II MHC Molecules,”Science258:659-662.
Vu et al., (1991)“Molecular Cloning of a Functional Thrombin Receptor Reveals a Novel Proteolytic Mechanism of Receptor Activation,”Cell64:1057-1068.
Vu et al., (1991) “Domains Specifying Thrombin-Receptor Interaction,”Nature353:674-677.
Haas et al., (1996) “Codon usage limitation in the expression of HIV-1 envelope glycoprotein,”Curr. Biol.6:315-324.
Zolotukhin et al., (1996) “A ‘Humanized’ Green Fluorescent Protein cDNA Adapted for High-Level Expression in Mammalian Cells,”J. Virol.70:4646-4654.
Tao and Levy, (1993) “Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma,”Nature362:755-758.
Chen et al., (1994) “Idiotype-Cytokine Fusion Proteins as Cancer Vaccines: Relative Efficacy of IL-2, IL-4, and Granulocyte-Macrophage Colony-Stimulating Factor,”J. Immunol.153:4775-4787.
Mehta-Damani et al., (1994) “Generation of Antigen-Specific CD8+ CTLs from Naive Precursors,”J. Immunol.153:996-1003.
Takamizawa et al., (1995) “Cellular and Molecular Basis of Human γδ T Cell Activation: Role of Accessory Molecules in Alloactivation,”J. Clin. Invest.95:296-303.
Kane et al., “Use of a Cloned Multidrug Resistance Gene for Coamplification and Overprotection of Major Excreted Protein, a transformation-Regulated Secreted Acid Protease,” Mol. Cell. Biol. 7:3316 (1988).
Cockett et al., “High Level Expression Of Tissue Inhibitor Of Metalloproteinases In Chinese Hamster Ovary Cells Using Glutamine Synthetase Gene Amplification,” Bio/Technology 8:662 (1990).
Bebbington, “Use of vectors based on gene amplification for the expression of cloned genes in mammalian cell,” In:DNA Cloning 4, A Practical Approach, Glower and Hames, eds., Oxford University Press pp. 85-111 (1995).
Chiang and McConlogue, “Amplification and Expression of Heterologous Omithine Decarboxylase in Chinese Hamster Ovary Cells,” Mol. Cell. Biol. 8:764 (1988).
Reff et al., “Depletion of B Cells In Vivo by a Chimeric Mouse Human monoclonal Antibody to CD20,” Blood 83:435 (1994).
Page and Sydenham, “High Level Expression of Humanized Monoclonal Antibody Campath-1H in Chinese Hamster Ovary Cells,” Bio/Technology 9:64 (1991).
Kim and Wold, “Stable Reduction of Thymidine Kinase Activity in Cells Expressing High Levels of Anti-Sense RNA,” Cell 42:129 (1985).
Gillies et al., “Expression Of Human Anti-Tetanus Toxoid Antibody in transfected Murine Myeloma Cells,” Bio/Technology 7:799 (1989).
Wood et al., “High Level Synthesis of Immunoglobulins in Chinese Hamster Ovary Cells,” J. Immunol. 145:3011 (1990).
Fouser et al., “High Level Expression Of A Chimeric Anti-Ganglioside GD2 Antibody: Genomic Kappa Sequences Improve Expression In COS And CHO Cells,” Bio/Technology 10:1121 (1992).
Davis et al., “High Level Expression in Chinese Hamster Ovary Cells of Soluble Forms of CD4 T Lymphocyte Glycoprotein Including Glycosylation Variants,” J. Biol.Chem. 265:10410 (1990).
Cartier et al., “Use of theEscherichia coliGene for Asparagine Synthetase as a Selective Marker in a Shuttle Vector Capable of Dominant Transfection and Amplification in Animal Cells,” Mol. Cell. Biol. 7:1623 (1987).
Cartier and Stanners, “Stable, high-level expression of a carcinoembryonic antigen-encoding cDNA after transfection and amplification with the dominant and selectable asparagine synthetase marker,” Gene 95:223 (1990).
Nakatani et al., “Functional Expression of Human Monoclonal Antibody Genes Directed Against Pseudomonal Exotoxin A In Mouse Myeloma Cells,” Bio/Technology 7:805 (1985).
Haagen, “Performance of CD3×CD19 bispecific monoclonal antibodies in B cell malignancy,” Leukemia and Lymphoma 19:381-393 (1995).
Scheinberg, “Current applicaitons of monoclonal antibodies for the therapy of hematopoetic cancers,” Current Opinion in Immunology 3:679-684 (1991).
Andrulis et al., “Isolation and characterization of chinese hamster ovary cell mutants resistant to the amino acid analogue beta-aspahydroxamate,” Somatic Cell Genetics 8:533-545 (1982).
Hawkins et al., “Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines,” Blood 83:3297 (1994).
Stevenson et al., “Idiotypic DNA vaccines against B-cell lymphoma,” Immunol. Rev. 145:211 (1995).
Tyler-Smith and Alderson, “Gene amplification in methotrexate-resistant mouse cells. I. DNA rearrangement accompanies dihydrofolate reductase gene amplification in a T-cell lymphoma,” J. Mol. Biol. 153:203 (1981).
Mason, et al.,Myelin Basic Protein Peptide Complexes with the Class II MHC Molecules I-Auamd I-AkForm and Dissociate Rapidly at Neutral pH. Journal of Immunology 154: 5216-5227 (May 15, 1995).
Sambrook, et al.,M

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Gene amplification methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene amplification methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene amplification methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2812978

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.